Misha Kudryshev’s lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression
A cellular link between obesity and atrial fibrillation -; a heart condition that afflicts over 33 million people worldwide -; presents a promising target for
Every day, people die waiting for an organ transplant. Time is at a premium, not just for those awaiting organs, but also for the organs
Today, the Allen Institute for Cell Science and New York Stem Cell Foundation (NYSCF) announced a pioneering collaboration to address this critical issue, combining two
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune cells.
Between 2012 and 2021, outsourcing propensity for FDA NDA injectables approvals averaged 40%, according to GlobalData’s Contract Injectable Packaging Trends in the Bio/Pharma Industry report.
The collaboration joins several rounds of funding in seeking to advance Acepodia’s promising ACC/γδ2 platforms. Image: Shutterstock / Yuri A. Taipei-based biotech Acepodia announced yesterday
Athira’s chief medical officer, Javier San Martin, pointed to “the lack of clinical decline in the placebo group” and “short duration of the study” as
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! Is your blue my blue?
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced